CDK6 and hepatocellular carcinoma: It reported that has-miR-195-497 cluster was intracellular antagonists of BMP signaling pathway in bone cells in and targeting cell cycle proteins CDK6, CCNE1, CDC25A and CDK4 to regulated cell proliferation in human hepatocellular carcinoma cells [44,45].